130 related articles for article (PubMed ID: 7680874)
1. Fludarabine phosphate in the treatment of chronic lymphocytic leukemia: biology, clinical impact, and future directions.
Robertson LE; Keating MJ
Cancer Treat Res; 1993; 64():105-19. PubMed ID: 7680874
[No Abstract] [Full Text] [Related]
2. Fludarabine shows promise for some leukemia patients.
Oncology (Williston Park); 1989 Mar; 3(3):14. PubMed ID: 2484283
[No Abstract] [Full Text] [Related]
3. Fludarabine phosphate--looking forward.
Cheson BD
Semin Oncol; 1990 Oct; 17(5 Suppl 8):1-2. PubMed ID: 1699277
[No Abstract] [Full Text] [Related]
4. Fludarabine phosphate: an effective therapy for lymphoid malignancies.
Semin Oncol; 1990 Oct; 17(5 Suppl 8):1-78. PubMed ID: 1699278
[No Abstract] [Full Text] [Related]
5. Fludarabine in chronic leukaemia.
Astrow AB
Lancet; 1996 May; 347(9013):1420-1. PubMed ID: 8676619
[No Abstract] [Full Text] [Related]
6. Efficacy and safety of oral fludarabine phosphate in previously untreated patients with chronic lymphocytic leukemia.
Rossi JF; van Hoof A; de Boeck K; Johnson SA; Bron D; Foussard C; Lister TA; Berthou C; Kramer MH; Littlewood TJ; Marcus RE; Deconinck E; Montillo M; Guibon O; Tollerfield SM
J Clin Oncol; 2004 Apr; 22(7):1260-7. PubMed ID: 15051774
[TBL] [Abstract][Full Text] [Related]
7. Fludarabine phosphate in lymphoma: an important new therapeutic agent.
McLaughlin P; Robertson LE; Keating MJ
Cancer Treat Res; 1996; 85():3-14. PubMed ID: 9043771
[No Abstract] [Full Text] [Related]
8. Fludarabine: a new agent with marked cytoreductive activity in untreated chronic lymphocytic leukemia.
Keating MJ; Kantarjian H; O'Brien S; Koller C; Talpaz M; Schachner J; Childs CC; Freireich EJ; McCredie KB
J Clin Oncol; 1991 Jan; 9(1):44-9. PubMed ID: 1702145
[TBL] [Abstract][Full Text] [Related]
9. Fludarabine phosphate in chronic lymphoproliferative diseases. The French Group on CLL.
Binet JL
Nouv Rev Fr Hematol (1978); 1993 Feb; 35(1):5-7. PubMed ID: 7685518
[TBL] [Abstract][Full Text] [Related]
10. Treatment of advanced chronic lymphocytic leukemia by fludarabine. Results of a clinical phase-II study.
Hiddemann W; Rottmann R; Wörmann B; Thiel A; Essink M; Ottensmeier C; Freund M; Büchner T; van de Loo J
Ann Hematol; 1991 Jul; 63(1):1-4. PubMed ID: 1715191
[TBL] [Abstract][Full Text] [Related]
11. Fludarabine phosphate. A new anticancer drug with significant activity in patients with chronic lymphocytic leukemia and in patients with lymphoma.
Rodriguez G
Invest New Drugs; 1994; 12(2):75-92. PubMed ID: 7532163
[TBL] [Abstract][Full Text] [Related]
12. Tumor lysis syndrome induced by fludarabine monophosphate: a case report.
Nakhoul F; Green J; Abassi ZA; Carter A
Eur J Haematol; 1996 Apr; 56(4):254-5. PubMed ID: 8641396
[No Abstract] [Full Text] [Related]
13. Astrovirus enteritis in a chronic lymphocytic leukemia patient treated with fludarabine monophosphate.
Coppo P; Scieux C; Ferchal F; Clauvel J; Lassoued K
Ann Hematol; 2000 Jan; 79(1):43-5. PubMed ID: 10663621
[TBL] [Abstract][Full Text] [Related]
14. [The use of fludarabine phosphate (Fludara) to treat chronic B-cell lymphocytic leukemia and non-Hodgkin's lymphoma resistant to standard chemotherapy].
Gershanovich ML; Zaritskiĭ AIu; Medvedeva NV; Abdulkadyrov KM; Samuskevich IG; Beresneva IA
Vopr Onkol; 1998; 44(6):696-700. PubMed ID: 10087967
[TBL] [Abstract][Full Text] [Related]
15. Fludarabine monophosphate: a potentially useful agent in chronic lymphocytic leukemia.
Grever MR; Kopecky KJ; Coltman CA; Files JC; Greenberg BR; Hutton JJ; Talley R; Von Hoff DD; Balcerzak SP
Nouv Rev Fr Hematol (1978); 1988; 30(5-6):457-9. PubMed ID: 2464793
[TBL] [Abstract][Full Text] [Related]
16. Why do drugs work in CLL?
Plunkett W; Begleiter A; Liliemark JO; Reed JC
Leuk Lymphoma; 1996 Oct; 22 Suppl 2():1-11. PubMed ID: 9021705
[No Abstract] [Full Text] [Related]
17. Activity of oral fludarabine phosphate in previously treated chronic lymphocytic leukemia.
Boogaerts MA; Van Hoof A; Catovsky D; Kovacs M; Montillo M; Zinzani PL; Binet JL; Feremans W; Marcus R; Bosch F; Verhoef G; Klein M
J Clin Oncol; 2001 Nov; 19(22):4252-8. PubMed ID: 11709569
[TBL] [Abstract][Full Text] [Related]
18. [Phase I clinical study of SH L573 (fludarabine phosphate) in patients with chronic lymphocytic leukemia and adult T-cell leukemia/lymphoma].
Arima N; Mizoguchi H; Shirakawa S; Tomonaga M; Takatsuki K; Ohno R
Gan To Kagaku Ryoho; 1999 Apr; 26(5):619-29. PubMed ID: 10234292
[TBL] [Abstract][Full Text] [Related]
19. Fludarabine therapy in chronic lymphocytic leukemia (CLL).
Keating MJ; Kantarjian H; Talpaz M; Redman J; McCredie KB
Nouv Rev Fr Hematol (1978); 1988; 30(5-6):461-6. PubMed ID: 2464794
[TBL] [Abstract][Full Text] [Related]
20. Fludarabine phosphate therapy in other lymphoid malignancies.
Kantarjian HM; Redman JR; Keating MJ
Semin Oncol; 1990 Oct; 17(5 Suppl 8):66-70. PubMed ID: 1699285
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
